help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seki, K.
Right arrow Articles by Shima, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seki, K.
Right arrow Articles by Shima, K.

Journal of Clinical Endocrinology & Metabolism, Vol 62, 783-784, Copyright © 1986 by Endocrine Society

ARTICLES

Absence of growth hormone response to L-dopa and bromocriptine in hyperprolactinemic women with pituitary microadenoma

K Seki, K Kato and K Shima

The administration of an amino acid precursor of both dopamine and norepinephrine, L-dopa, or of a dopamine agonist, bromocriptine, did not alter basal GH secretion in hyperprolactinemic women with pituitary microadenoma, whereas both significantly increased serum GH levels in normal women. The findings cannot be accounted for by decreased pituitary GH reserve, since in hyperprolactinemic women, insulin elicited an increase in GH levels similar to its action in normal women. Thus, the mechanism by which L-dopa or bromocriptine stimulates GH secretion appears to be different from that of insulin.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society